Literature DB >> 95532

Towards the clinical use of interferon.

K Cantell.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 95532     DOI： 10.1016/0160-9327(78)90030-3

Source DB:  PubMed          Journal:  Endeavour        ISSN： 0160-9327            Impact factor:   0.444


× No keyword cloud information.
  2 in total

1.  Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.

Authors:  P W Doetsch; R J Suhadolnik; Y Sawada; J D Mosca; M B Flick; N L Reichenbach; A Q Dang; J M Wu; R Charubala; W Pfleiderer; E E Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

2.  Production of interferon by human tumor cell lines.

Authors:  P Jameson; S E Grossberg
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.